Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway

By Haldorsen Ingfrid Salvesen   Aarseth Jan Harald   Hollender Aase   Larsen John Ludvig   Espeland Ansgar   Mella Olav  

Acta Oncologica, Vol. 43, Iss. 6, 2004-09 ,pp. : 520-529

Informa Healthcare

Access to resources Recommend Favorite

Angiogenesis in primary central nervous system lymphoma (PCNSL)

By Takeuchi Hiroaki   Matsuda Ken   Kitai Ryuhei   Sato Kazufumi   Kubota Toshihiko  

Journal of Neuro-Oncology, Vol. 84, Iss. 2, 2007-09 ,pp. : 141-145

Springer Publishing Company

Access to resources Recommend Favorite

Diagnostic delay in primary central nervous system lymphoma

By Haldorsen Ingfrid S.   Espeland Ansgar   Larsen John Ludvig   Mella Olav  

Acta Oncologica, Vol. 44, Iss. 7, 2005-10 ,pp. : 728-734

Informa Healthcare

Access to resources Recommend Favorite

Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors

By Jahnke Kristoph   Thiel Eckhard   Martus Peter   Herrlinger Ulrich   Weller Michael   Fischer Lars   Korfel Agnieszka  

Journal of Neuro-Oncology, Vol. 80, Iss. 2, 2006-11 ,pp. : 159-165

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic value of pretreatment ¹⁸F-FDG PET in patients with primary central nervous system lymphoma: SUV-based assessment

By Kawai Nobuyuki   Zhen Hai-Ning   Miyake Keisuke   Yamamaoto Yuka   Nishiyama Yoshihiro   Tamiya Takashi  

Journal of Neuro-Oncology, Vol. 100, Iss. 2, 2010-11 ,pp. : 225-232

Springer Publishing Company

Access to resources Recommend Favorite